Rosacea Treatment Market Worth USD 10.72 Billion by 2028 | CAGR: 5.97%

Market Overview:
The global Rosacea Treatment Market was valued at USD 7.58 Billion in 2021 and is expected to reach USD 10.72 Billion by the year 2028, at a CAGR of 5.97%.

Rosacea is a common inflammatory skin disorder that is commonly characterized by skin redness. Additionally, it causes tiny, red, pus-filled pimples that are provoked by heat, caffeine, or stress. The nose, cheeks, and forehead are where rosacea symptoms are most noticeable, but they can also affect the chest, ears, and back. The topical treatment is the preferred method for treating rosacea, corticosteroids, retinoids, alpha agonists, antibiotics, and immunosuppressants would gain popularity. Laser therapy is also used for rosacea treatment.

Read More:
https://introspectivemarketresearch.com/reports/rosacea-treatments-market/

Market Dynamics:
Driver:
The increasing prevalence of acne diseases and the rise in the availability of generic medicines for rosacea provides growth for the market. Dermatologists report that rosacea incidence rates are relatively high and that fair-skinned people seem to be more susceptible to the condition. The diversity of the population should be considered while evaluating rosacea in an individual. For instance, regardless of the women's ethnic background, the prevalence rate of rosacea was 9.6%, according to Howard's Medical School research. In contrast to the rates in Ireland and Sweden, the prevalence rate among Caucasian women alone was 16% at the time, and it propels the growth of Rosacea Treatment.

Opportunities:
The rapid change in lifestyle and the resulting altered environment due to global warming has accelerated the spread of various skin problems. The majority of those affected by this condition are those with very light skin tones who reside in the European and American continents. Market players might focus on these areas and introduce new rosacea-related items there that will assist lessen difficulties. Market participants might perform voluntary trials in this area to develop remedies that can fit patients' skin conditions in this area. Additionally, these regions' governments are funding R&D initiatives that provide the opportunity for the growth of the market for rosacea treatments.

For Request Sample:
https://introspectivemarketresearch.com/request/16097

Market Segmentation
Segmentation Analysis of Rosacea Treatment Market
Depending on the disease type, Erythematotelangiectatic {ETR} rosacea dominated the market and is expected to do the same in the forecast period. ETR rosacea is the most common type affecting both genders. Near about 80% of the total population affected by rosacea is suffering from ETR. Individuals with ETR are mainly affected by facial redness, visible surface blood vessels, and flushing. 'Erythema' is the medical term dermatologists use for redness, 'telangiectasias' are visible surface blood vessels. Patients with this type of rosacea experience a prolonged flushing period, a burning and stinging sensation after being exposed to certain environmental factors.
• Erythematotelangiectatic
• Papulopustular
• Phymatous
• Ocular

Depending on the treatment type, the laser therapy segment is expected to lead the rosacea treatment market in the analysis period. The heat from the light wavelength is utilized by lasers to treat the tiny, swollen red blood cells. This is a painless therapy and the results last for years. Laser therapy improves the texture of the skin and patients observe a 50-70 % reduction in their symptoms after one to three treatments. Laser therapy has fewer side effects and has long-lasting effects thus, driving the growth of the segment.
• Laser Treatment
• Electrocautery
• Surgery
• Others

Depending on the distribution channel, the commercial drug store segment is anticipated to lead the rosacea treatment market over the projected period. There has been a significant rise in the number of patients suffering from rosacea even though, most people prefer OTC to treat the symptoms. The large-scale presence of commercial drug stores and the discounts offered by them on different medications are the essential factors expected to propel the expansion of the rosacea market.
• Commercial Drug Stores
• Hospital Stores

Regional Analysis of Rosacea Treatment Market
The European region is forecasted to dominate the rosacea treatment market during the forecast period. This skin condition is the most common found in the individuals living in this region. Epidemiological studies have shown that 10% of the Swedish population have rosacea followed by the French and German population, each accounting for 2-3% prevalence. According to the European Academy of Dermatology and Venerology (EADV), near about half (47.9%) of the total European population experienced at least one dermatological condition in 2021. Atopic dermatitis (eczema) (5.34%), and acne (5.49%) were the second most and third most skin disorders respectively. Thus, the growing number of skin-related disorders is expected to drive the growth of the rosacea market in this region.

The North American region is anticipated to have the second-highest share of the rosacea treatment market over the forecast period. According to the American Academy of Dermatology, rosacea affects at least 14 million adults in the United States, or around one out of every ten people. The National Rosacea Society (NRS) estimates that there are now 16 million people living with Rosacea. Despite its relatively high prevalence, rosacea is frequently misdiagnosed or left undiagnosed. The consequence is needless suffering for many patients. The presence of prominent market players and the launch of innovative products to treat the skin conditions of patients are the essential factors expected to consolidate the development of the market in this region.

The rosacea treatment market in the Asia-Pacific region is expected to develop at a significant growth rate in the analysis period. The changing lifestyle, rise in pollution, and global warming are factors responsible for the development of rosacea in people inhabiting this region. Rapid urbanization and industrialization have triggered the factors that may cause rosacea in a certain group of individuals. The growing adoption of cosmetics and the increasing smoker's population may drive the incidence rates of rosacea thus, strengthening the growth of the market in this region.
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of SA)

Have a query? Make an Enquiry before Purchase @
https://introspectivemarketresearch.com/inquiry/16097

Players Covered in Rosacea Treatments market are :
• Nestle Skin (US)
• GlaxoSmithKline plc (UK)
• Viatris Inc. (US)
• Body Glide (US)
• Sun Pharma (India)
• Perrigo (Ireland)
• Bayer (Germany)
• Pfizer (US)
• Teva (Israel)
• Allergan (Ireland)
• Bausch Health (Canada)
• Almirall (Spain)

Recent Industry Developments in Rosacea Treatment Market
In June 2021, Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd, has launched a generic version of SOOLANTRA® (ivermectin) Cream, 1% for the treatment of rosacea inflammatory lesions in the United States.

In November 2021, Sun Pharmaceutical Industries announced the availability of WINLEVI (clascoterone) cream 1% for patients in the United States (U.S). WINLEVI is a first-in-class topical androgen receptor inhibitor and was approved by the U.S. Food and Drug Administration (FDA) in August 2020 for the topical treatment of acne vulgaris in patients 12 years of age and older.

The report systematically covers analyzed understandings in view of the market; along with its ever-changing patterns, industry environment, and all leading characteristics of the market. This research methodology has been applied to examine the global Rosacea Treatment market and these results have been reasonably mentioned in the report. The Rosacea Treatment research Report is the most comprehensive report available on this market and will help gain a global perspective as it covers 60 geographies. The regional and country breakdowns section analyses the market in each geography and the size of the market by region and country.

Purchase This Premium Report Now
https://introspectivemarketresearch.com/checkout/?user=1&_sid=16097

Related Reports:
https://introspectivemarketresearch.com/reports/sensitive-skin-care-product-market/

https://introspectivemarketresearch.com/reports/skin-tightening-treatment-market/

https://introspectivemarketresearch.com/reports/probiotic-skin-care-cosmetic-product-market/

Contact Us:
Mike Cooper
Business Development Manager
3001 S King Drive, Chicago, Illinois,
U.S. A 60616
Contact No: USA: +1 (773)-382-1047 / IND: +91-81-8009-6367
Email: sales@introspectivemarketresearch.com

About Us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyse extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

This release was published on openPR.